Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


August 30, 2015 11:14 PM ET

Biotechnology

Company Overview of VaxInnate Corporation

Company Overview

VaxInnate Corporation is a biotechnology company which develops and produces vaccines for pandemic and seasonal influenza diseases. Its products include Flagellin.HuHA and flagellin.AvHA, which are fusion proteins linking a potent immune stimulator, the bacterial protein flagellin, with immunoprotective domain of viral hemagglutinin. The company's products are used in the treatment of various diseases, including bacterial, viral, and parasitic infections. VaxInnate Corporation was incorporated in 2001 and is headquartered in Cranbury, New Jersey.

3 Cedar Brook Drive

Suite 1

Cranbury, NJ 08512

United States

Founded in 2001

Phone:

609-860-2260

Fax:

609-860-2290

Key Executives for VaxInnate Corporation

Chief Executive Officer, President and Director
Age: 60
Scientific Founder
Scientific Founder
Chief Financial Officer
Age: 54
Vice President of Business Development
Age: 56
Compensation as of Fiscal Year 2015.

VaxInnate Corporation Key Developments

VaxInnate, Inc. Presents at Cantor Fitzgerald's Inaugural Healthcare Conference, Jul-08-2015 10:45 AM

VaxInnate, Inc. Presents at Cantor Fitzgerald's Inaugural Healthcare Conference, Jul-08-2015 10:45 AM. Venue: Le Parker Meridien Hotel, 119 W. 56th Street, New York, NY 10019, United States. Speakers: Wayne F. Pisano, Chief Executive Officer, President and Director.

VaxInnate Corporation Appoints Thomas P. Monath to Board of Directors

VaxInnate Corporation announced the appointment of Thomas P. Monath, MD to the Company's board of directors. Dr. Monath is an internationally known virologist and vaccinologist with significant experience in the biotechnology industry and at the Centers for Disease Control and Prevention (CDC). Dr. Monath currently serves as the chief scientific and chief operating officer of BioProtection Systems, a subsidiary of NewLink Genetics Corporation, where he is leading the development of an Ebola virus vaccine in partnership with Merck. Prior to joining NewLink, Tom held various industry roles at PaxVax Inc., Hookipa Biotech AG, Juvaris Inc., Xcellerex Inc. and Acambis Inc. prior to its acquisition by Sanofi Pasteur. In these roles, he was involved in the development of a broad array of vaccines including those for cholera, influenza, polio, malaria, HIV, anthrax, dengue, Japanese encephalitis, West Nile, yellow fever, Clostridium difficile and smallpox.

VaxInnate, Inc. Presents at Needham & Company's 14th Annual Healthcare Conference, Apr-15-2015 10:00 AM

VaxInnate, Inc. Presents at Needham & Company's 14th Annual Healthcare Conference, Apr-15-2015 10:00 AM. Venue: Westin Grand Central Hotel, New York, New York, United States. Speakers: Wayne F. Pisano, Chief Executive Officer, President and Director.

Similar Private Companies By Industry

Company Name Region
BioVitesse, Inc. United States
MesoBio LLC United States
Trifocal LLC United States
DecImmune Therapeutics, Inc. United States
Centrose LLC United States

Recent Private Companies Transactions

Type
Date
Target
Private Placement
September 25, 2014
--
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
NYC2012, Inc. United States
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact VaxInnate Corporation, please visit www.vaxinnate.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.